BioTek Announces Establishment of Japanese Office
News Jun 10, 2013
BioTek Instruments, Inc., continues their global expansion in the microplate-based technology market with the establishment of BioTek Japan.
Managed by Mr. Satoshi Sagara, the new direct sales and service organization in Tokyo will focus on growing BioTek's brand and expanding the sales network in Japan.
Long-time partner and distributor, DS Pharma Biomedical Co., Ltd., will work closely with BioTek Japan to ensure a seamless transition.
BioTek Japan will continue to work with existing distributor, Central Scientific Comm., Inc., to grow the Japanese business.
"The establishment of BioTek Japan will allow BioTek to increase our presence in this very important marketplace," commented Briar Alpert, BioTek President and CEO.
Alpert continued, "In addition to providing local service and application support, our customers in Japan will have direct access to the company's global scientific and applications resources. Ultimately, this will lead to enhanced customer satisfaction for our Japanese customers."
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
PhoreMost and o2h Discovery Collaborate to Progress First-in-Class Drug Discovery ProgramsNews
PhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has entered into a collaboration with o2h discovery (o2h), an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage.READ MORE
Integrated Lead Discovery: An Evolving ToolboxNews
A new SLAS Discovery review article offers an informative guide to the established and emerging tools available for early drug discovery and screening, and provides illustrative scenarios demonstrating considerations that drive decisions on choice of lead discovery tactics.READ MORE